Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ROGAINE (FOR MEN) | Johnson & Johnson | N-019501 OTC | 1996-02-09 | 1 products, RLD, RS |
ROGAINE (FOR WOMEN) | Johnson & Johnson | N-019501 OTC | 1996-02-09 | 1 products, RLD, RS |
ROGAINE EXTRA STRENGTH (FOR MEN) | Johnson & Johnson | N-020834 OTC | 1997-11-14 | 1 products, RLD, RS |
WOMEN'S ROGAINE | Johnson & Johnson | N-021812 OTC | 2014-02-28 | 1 products, RLD, RS |
MEN'S ROGAINE | Johnson & Johnson | N-021812 OTC | 2006-01-20 | 1 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
betamethasone dipropionate 0.05% / minoxidil 5% | unapproved drug other | 2019-04-24 |
betamethasone dipropionate 0.05% / minoxidil 5% / niacinamide 2% / pentoxifylline 0.5% | unapproved drug other | 2019-05-08 |
betamethasone diproprionate 0.05% / minoxidil 7% | unapproved drug other | 2019-05-09 |
dexamethasone sodium phosphate 0.1% / finasteride 0.1% / minoxidil 5% | unapproved drug other | 2019-05-08 |
dexamethasone sodium phosphate 0.1% / finasteride 0.1% / minoxidil 5% / tretinoin 0.025% | unapproved drug other | 2019-05-08 |
finasteride 0.1% / minoxidil 5% | unapproved drug other | 2019-05-08 |
finasteride 0.1% / minoxidil 7% | unapproved drug other | 2019-04-24 |
finasteride 0.1% / minoxidil 7% / tretinoin 0.025% | unapproved drug other | 2019-05-10 |
fluocinolone acetonide 0.01% / minoxidil 5% / tretinoin 0.025% | unapproved drug other | 2019-05-08 |
fluocinolone acetonide 0.01% / minoxidil 7% / progesterone 0.1% | unapproved drug other | 2019-05-08 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
alopecia | HP_0002293 | D000505 | L64 |
malignant hypertension | EFO_1001031 | D006974 | — |
Code | Description |
---|---|
S0139 | Minoxidil, 10 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Alopecia | D000505 | HP_0002293 | L64 | 7 | 15 | 11 | 3 | 7 | 37 |
Alopecia areata | D000506 | EFO_0004192 | L63 | — | 1 | — | 1 | 1 | 3 |
Hypotrichosis | D007039 | HP_0008070 | — | 1 | — | — | 1 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Polycystic kidney diseases | D007690 | HP_0000113 | Q61.3 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Self-assessment | D012647 | — | — | 1 | 1 | — | — | — | 1 |
Williams syndrome | D018980 | Orphanet_904 | Q93.82 | — | 1 | — | — | — | 1 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | — | 1 | — | — | — | 1 |
Acne vulgaris | D000152 | EFO_0003894 | L70 | 1 | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypertension | D006973 | EFO_0000537 | I10 | — | — | — | — | 3 | 3 |
Covid-19 | D000086382 | — | U07.1 | — | — | — | — | 1 | 1 |
Fissure in ano | D005401 | HP_0012390 | K60.2 | — | — | — | — | 1 | 1 |
Drug common name | Minoxidil |
INN | minoxidil |
Description | Minoxidil is a pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6. It has a role as a vasodilator agent and an antihypertensive agent. It is a pyrimidine N-oxide, a member of piperidines and an aminopyrimidine. |
Classification | Small molecule |
Drug class | vasodilators (undefined group) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | Nc1cc(N2CCCCC2)nc(N)[n+]1[O-] |
PDB | — |
CAS-ID | 38304-91-5 |
RxCUI | — |
ChEMBL ID | CHEMBL802 |
ChEBI ID | 6942 |
PubChem CID | 4201 |
DrugBank | DB00350 |
UNII ID | 5965120SH1 (ChemIDplus, GSRS) |